Alcohol Consumption clinical trials

Explore recruiting alcohol consumption clinical trials.

Recruiting alcohol consumption studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Alcohol Consumption trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Two-part, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2 Study to Evaluate Impact of Sunobinop (V117957) on Alcohol Consumption (Part A) and Alcohol Craving (Part B) in Subjects Diagnosed with Moderate to Severe Alcohol Use Disorder and Seeking Treatment

Romania

Therapeutic exploratory (Phase II) EU CTIS Study details

Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy & (Neuro)Cognitive Mechanisms

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Effect of tirzepatide on alcohol intake and reward processing in patients diagnosed with schizophrenia and alcohol use disorder

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Efficacy, tolerability and preferences of per oral or subcutaneous methotrexate in patients with early rheumatoid arthritis – a randomised register based multicentre study

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

CIRAANO: Multimodal exploration (including radiopharmaceuticals Amyvid® and Tauvid®) of theater actors, memory athletes, and patients with various memory pathologies: evaluation of mnesic strategies and their cerebral substrates, and contribution to the treatment of memory pathologies.

France

Phase II and Phase III (Integrated) EU CTIS Study details

Efficacy and safety of Sodium Oxybate in reducing alcohol consumption and maintaining abstinence in alcohol-dependent subjects with high and very high drinking risk level

Italy, France, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Alcohol Consumption trials by city

Alcohol Consumption in Toronto Alcohol Consumption in Vancouver Alcohol Consumption in Montreal Alcohol Consumption in Calgary Alcohol Consumption in Edmonton Alcohol Consumption in Ottawa Alcohol Consumption in Winnipeg Alcohol Consumption in Quebec City Alcohol Consumption in Hamilton Alcohol Consumption in Kitchener Alcohol Consumption in London Alcohol Consumption in Halifax Alcohol Consumption in New York Alcohol Consumption in Los Angeles Alcohol Consumption in Chicago Alcohol Consumption in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease